![News Logos5 News Logos5](https://usbiologic.com/wp-content/uploads/2021/12/News-Logos5-300x188.jpg)
US Biologic Broadens Intellectual Property Platform in Prevention of Zoonotic Disease
US Biologic, a leading oral vaccine and therapeutic delivery company, today announced that the United States Patent and Trademark Office has issued U.S. Patent #1065360 entitled “Composition & Method for Reducing Zoonotic Infectious Diseases.” The patent extends the US Biologic OrisBio™ oral-delivery technology platform in the creation of orally delivered vaccines.